H. Inaba, M. Greaves, and C. G. Mullighan, Acute lymphoblastic leukaemia, Lancet Lond Engl. 1 juin, vol.381, issue.9881, pp.1943-55, 2013.

D. P. Sandler and J. A. Ross, Epidemiology of acute leukemia in children and adults, Semin Oncol. févr, vol.24, issue.1, pp.3-16, 1997.

J. W. Taub, Relationship of chromosome 21 and acute leukemia in children with Down syndrome, J Pediatr Hematol Oncol. avr, vol.23, issue.3, pp.175-183, 2001.

D. L. Shore, D. P. Sandler, F. R. Davey, O. R. Mcintyre, and C. D. Bloomfield, Acute leukemia and residential proximity to potential sources of environmental pollutants, Arch Environ Health. déc, vol.48, issue.6, pp.414-434, 1993.

T. T. Timonen, A hypothesis concerning deficiency of sunlight, cold temperature, and influenza epidemics associated with the onset of acute lymphoblastic leukemia in northern Finland, Ann Hematol. sept, vol.78, issue.9, pp.408-422, 1999.

C. G. Mullighan, The molecular genetic makeup of acute lymphoblastic leukemia, Hematol Am Soc Hematol Educ Program, vol.2012, pp.389-96, 2012.

D. A. Arber, A. Orazi, R. Hasserjian, J. Thiele, M. J. Borowitz et al., The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia, Blood. 19 mai, vol.127, issue.20, pp.2391-405, 2016.

J. Van-dongen, L. Lhermitte, S. Böttcher, J. Almeida, V. Van-der-velden et al., EuroFlow antibody panels for standardized n-dimensional flow cytometric immunophenotyping of normal, reactive and malignant leukocytes, Leukemia. sept, vol.26, issue.9, pp.1908-75, 2012.

M. C. Bene, G. Castoldi, W. Knapp, W. D. Ludwig, E. Matutes et al., Proposals for the immunological classification of acute leukemias. European Group for the Immunological Characterization of Leukemias (EGIL), Leukemia. oct, vol.9, issue.10, pp.1783-1789, 1995.

E. Matutes, W. F. Pickl, M. Van't-veer, R. Morilla, J. Swansbury et al., Mixedphenotype acute leukemia: clinical and laboratory features and outcome in 100 patients defined according to the WHO 2008 classification, Blood. 17 mars, vol.117, issue.11, pp.3163-71, 2011.

B. Gleissner, N. Gökbuget, C. R. Bartram, B. Janssen, H. Rieder et al., Leading prognostic relevance of the BCR-ABL translocation in adult acute B-lineage lymphoblastic leukemia: a prospective study of the German Multicenter Trial Group and confirmed polymerase chain reaction analysis, Blood. 1 mars, vol.99, issue.5, pp.1536-1579, 2002.

A. Trinquand, A. Tanguy-schmidt, B. Abdelali, R. Lambert, J. Beldjord et al., Toward a NOTCH1/FBXW7/RAS/PTEN-based oncogenetic risk classification of adult T-cell acute lymphoblastic leukemia: a Group for Research in Adult Acute Lymphoblastic Leukemia study, J Clin Oncol Off J Am Soc Clin Oncol. 1 déc, vol.31, issue.34, pp.4333-4375, 2013.
URL : https://hal.archives-ouvertes.fr/hal-00979452

E. Clappier, N. Grardel, M. Bakkus, J. Rapion, B. De-moerloose et al., IKZF1 deletion is an independent prognostic marker in childhood B-cell precursor acute lymphoblastic leukemia, and distinguishes patients benefiting from pulses during maintenance therapy: results of the EORTC Children's Leukemia Group study 58951, Leukemia. nov, vol.29, issue.11, pp.2154-61, 2015.

A. V. Moorman, C. J. Harrison, G. Buck, S. M. Richards, L. M. Secker-walker et al., Karyotype is an independent prognostic factor in adult acute lymphoblastic leukemia (ALL): analysis of cytogenetic data from patients treated on the Medical Research Council (MRC) UKALLXII/Eastern Cooperative Oncology Group (ECOG) 2993 trial, Blood. 15 avr, vol.109, issue.8, pp.3189-97, 2007.

R. Garand, K. Beldjord, H. Cavé, C. Fossat, I. Arnoux et al., Flow cytometry and IG/TCR quantitative PCR for minimal residual disease quantitation in acute lymphoblastic leukemia: a French multicenter prospective study on behalf of the FRALLE, EORTC and GRAALL. Leukemia. févr, vol.27, issue.2, pp.370-376, 2013.

P. Stow, L. Key, X. Chen, Q. Pan, G. A. Neale et al., Clinical significance of low levels of minimal residual disease at the end of remission induction therapy in childhood acute lymphoblastic leukemia, Blood. 10 juin, vol.115, issue.23, pp.4657-63, 2010.

F. Huguet, T. Leguay, E. Raffoux, X. Thomas, K. Beldjord et al., Pediatricinspired therapy in adults with Philadelphia chromosome-negative acute lymphoblastic leukemia: the GRAALL-2003 study, J Clin Oncol Off J Am Soc Clin Oncol. 20 févr, vol.27, issue.6, pp.911-919, 2009.

V. Gupta, S. Richards, and J. Rowe, Acute Leukemia Stem Cell Transplantation Trialists' Collaborative Group. Allogeneic, but not autologous, hematopoietic cell transplantation improves survival only among younger adults with acute lymphoblastic leukemia in first remission: an individual patient data meta-analysis, Blood. 10 janv, vol.121, issue.2, pp.339-50, 2013.

N. Gökbuget, M. Kneba, T. Raff, H. Trautmann, C. Bartram et al., Adult patients with acute lymphoblastic leukemia and molecular failure display a poor prognosis and are candidates for stem cell transplantation and targeted therapies, Blood. 30 août, vol.120, issue.9, pp.1868-76, 2012.

N. Dhédin, A. Huynh, S. Maury, R. Tabrizi, K. Beldjord et al., Role of allogeneic stem cell transplantation in adult patients with Ph-negative acute lymphoblastic leukemia, Blood. 16 avr, vol.125, issue.16, pp.2486-2496, 2015.

K. Beldjord, S. Chevret, V. Asnafi, F. Huguet, M. Boulland et al., Oncogenetics and minimal residual disease are independent outcome predictors in adult patients with acute lymphoblastic leukemia, Blood. 12 juin, vol.123, issue.24, pp.3739-3788, 2014.

S. Maury, S. Chevret, X. Thomas, D. Heim, T. Leguay et al., associated diarrhea: a cohort study during an epidemic in Quebec, Clin Infect Dis Off Publ Infect Dis Soc Am, vol.375, issue.11, pp.1254-60, 2005.

S. Y. Park, C. Kang, E. Joo, Y. E. Ha, Y. M. Wi et al., Risk factors for multidrug resistance in nosocomial bacteremia caused by extended-spectrum ?-lactamase-producing Escherichia coli and Klebsiella pneumoniae. Microb Drug Resist Larchmt N, vol.18, pp.518-542, 2012.

M. Ruhnke, R. Arnold, and P. Gastmeier, Infection control issues in patients with haematological malignancies in the era of multidrug-resistant bacteria, Lancet Oncol. déc, vol.15, issue.13, pp.606-619, 2014.

D. Averbuch, C. Orasch, C. Cordonnier, D. M. Livermore, M. Mikulska et al., European guidelines for empirical antibacterial therapy for febrile neutropenic patients in the era of growing resistance: summary of the, 4th European Conference on Infections in Leukemia, vol.98, pp.1826-1861, 2011.

D. Averbuch, C. Cordonnier, D. M. Livermore, M. Mikulska, C. Orasch et al., Targeted therapy against multi-resistant bacteria in leukemic and hematopoietic stem cell transplant recipients: guidelines of the 4th European Conference on Infections in Leukemia, vol.98, pp.1836-1883, 2011.

M. Mikulska, D. Bono, V. Viscoli, and C. , Bacterial infections in hematopoietic stem cell transplantation recipients, Curr Opin Hematol, vol.21, issue.6, pp.451-459, 2014.

D. Cote, Hematology department

, Hematology

, Hematology

, Hematology

, Hematology

H. Hematology, Becquerel Anti-Cancer Center

, Hematology, Strasbourg University Hospital

, Hematology

, Hematology, vol.11

, Angers University Hospital

I. U1065, Mediterranean center of molecular medicine

S. Amit, H. Mishali, T. Kotlovsky, M. J. Schwaber, and Y. Carmeli, Bloodstream infections among carriers of carbapenem-resistant Klebsiella pneumoniae: etiology, incidence and predictors, Clin Microbiol Infect Off Publ Eur Soc Clin Microbiol Infect Dis. janv, vol.21, issue.1, pp.30-34, 2015.

G. Gustinetti and M. Mikulska, Bloodstream infections in neutropenic cancer patients: A practical update, Virulence. 2 avr, vol.7, issue.3, pp.280-97, 2016.

E. Meyer, J. Beyersmann, H. Bertz, S. Wenzler-röttele, R. Babikir et al., Risk factor analysis of blood stream infection and pneumonia in neutropenic patients after peripheral blood stem-cell transplantation, Bone Marrow Transplant. févr, vol.39, issue.3, pp.173-181, 2007.

S. H. Zinner, Changing epidemiology of infections in patients with neutropenia and cancer: emphasis on gram-positive and resistant bacteria, Clin Infect Dis Off Publ Infect Dis Soc Am. sept, vol.29, issue.3, pp.490-494, 1999.

J. Klastersky, L. Ameye, J. Maertens, A. Georgala, F. Muanza et al., Bacteraemia in febrile neutropenic cancer patients, Int J Antimicrob Agents, vol.30, issue.1, pp.51-59, 2007.

S. Alp and M. Akova, Management of febrile neutropenia in the era of bacterial resistance, Ther Adv Infect Dis. févr, vol.1, issue.1, pp.37-43, 2013.

J. Mebis, H. Goossens, and Z. N. Berneman, Antibiotic management of febrile neutropenia: current developments and future directions, J Chemother Florence Italy. févr, vol.22, issue.1, pp.5-12, 2010.

C. Macdougall, J. P. Powell, C. K. Johnson, M. B. Edmond, and R. E. Polk, Hospital and community fluoroquinolone use and resistance in Staphylococcus aureus and Escherichia coli in 17 US hospitals, Clin Infect Dis Off Publ Infect Dis Soc Am. 15 août, vol.41, issue.4, pp.435-475, 2005.

J. Pépin, N. Saheb, M. Coulombe, M. Alary, M. Corriveau et al., Emergence of fluoroquinolones as the predominant risk factor for Clostridium difficileassociated diarrhea: a cohort study during an epidemic in Quebec, Clin Infect Dis Off Publ Infect Dis Soc Am, vol.41, issue.9, pp.1254-60, 2005.

G. Rangaraj, B. P. Granwehr, Y. Jiang, R. Hachem, and I. Raad, Perils of quinolone exposure in cancer patients: breakthrough bacteremia with multidrug-resistant organisms, Cancer. 15 févr, vol.116, issue.4, pp.967-73, 2010.

S. Y. Park, C. Kang, E. Joo, Y. E. Ha, Y. M. Wi et al., Risk factors for multidrug resistance in nosocomial bacteremia caused by extended-spectrum ?-lactamase-producing Escherichia coli and Klebsiella pneumoniae. Microb Drug Resist Larchmt N, vol.18, pp.518-542, 2012.

M. Ruhnke, R. Arnold, and P. Gastmeier, Infection control issues in patients with haematological malignancies in the era of multidrug-resistant bacteria, Lancet Oncol. déc, vol.15, issue.13, pp.606-619, 2014.

D. Averbuch, C. Orasch, C. Cordonnier, D. M. Livermore, M. Mikulska et al., European guidelines for empirical antibacterial therapy for febrile neutropenic patients in the era of growing resistance: summary of the, 4th European Conference on Infections in Leukemia, vol.98, pp.1826-1861, 2011.

M. Mikulska, D. Bono, V. Viscoli, and C. , Bacterial infections in hematopoietic stem cell transplantation recipients, Curr Opin Hematol, vol.21, issue.6, pp.451-459, 2014.

A. G. Freifeld, E. J. Bow, K. A. Sepkowitz, M. J. Boeckh, J. I. Ito et al., Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the infectious diseases society of america, Clin Infect Dis Off Publ Infect Dis Soc Am. 15 févr, vol.52, issue.4, pp.56-93, 2011.

E. González-barca, A. Fernández-sevilla, J. Carratalá, A. Grañena, and F. Gudiol, Prospective study of 288 episodes of bacteremia in neutropenic cancer patients in a single institution

, Eur J Clin Microbiol Infect Dis Off Publ Eur Soc Clin Microbiol. avr, vol.15, issue.4, pp.291-297, 1996.

M. Akova, Epidemiology of antimicrobial resistance in bloodstream infections, Virulence. 2 avr, vol.7, issue.3, pp.252-66, 2016.

S. Maury, S. Chevret, X. Thomas, D. Heim, T. Leguay et al., Rituximab in BLineage Adult Acute Lymphoblastic Leukemia, N Engl J Med. 15 sept, vol.375, issue.11, pp.1044-53, 2016.
URL : https://hal.archives-ouvertes.fr/hal-01812704

D. Averbuch, C. Cordonnier, D. M. Livermore, M. Mikulska, C. Orasch et al., Targeted therapy against multi-resistant bacteria in leukemic and hematopoietic stem cell transplant recipients: guidelines of the 4th European Conference on Infections in Leukemia, vol.98, pp.1836-1883, 2011.

L. R. Baden, W. Bensinger, M. Angarone, C. Casper, E. R. Dubberke et al., Prevention and treatment of cancer-related infections, J Natl Compr Cancer Netw JNCCN, vol.10, issue.11, pp.1412-1457, 2012.

F. Huguet, T. Leguay, E. Raffoux, X. Thomas, K. Beldjord et al., Pediatricinspired therapy in adults with Philadelphia chromosome-negative acute lymphoblastic leukemia: the GRAALL-2003 study, J Clin Oncol Off J Am Soc Clin Oncol. 20 févr, vol.27, issue.6, pp.911-919, 2009.